1.
1
Campbell JD
.
Lifestyle, minerals and health
.
Med Hypotheses
. 2001;57:521–531
.
Abstract |
Full-Text PDF (213 KB)
|
CrossRef
2.
2
Snively CS
, Gutierrez C
.
Chronic kidney disease: prevention and treatment of common complications
.
Am Fam Physician
. 2004;70:1921–1928
.
3.
3
Kumai T
, Oonuma S
, Kitaoka Y
, Tadokoro M
, Kobayashi S
.
Biochemical and morphological characterization of spontaneously hypertensive hyperlipidaemic rats
.
Clin Exp Pharmacol Physiol
. 2003;30:537–544
.
MEDLINE |
CrossRef
4.
4
Madore F
.
Vascular risk factors and renal failure
.
Med Sci
. 2004;20:1100–1103
.
5.
5
Campos SB
, Ori M
, Dórea EL
, Seguro AC
.
Protective effect of L-arginine on hypercholesterolemia-enhanced renal ischemic injury
.
Atherosclerosis
. 1999;143:327–334
.
Abstract | Full Text |
Full-Text PDF (228 KB)
|
CrossRef
6.
6
Kelly KJ
.
Distant effects of experimental renal ischemia/reperfusion injury
.
J Am Soc Nephrol
. 2003;14:1549–1558
.
MEDLINE |
CrossRef
7.
7
Erdogan H
, Fadillioglu E
, Yagmurca M
, Ucar M
, Irmak MK
.
Protein oxidation and lipid peroxidation after renal ischemiareperfusion injury: protective effects of erdosteine and N-acetylcysteine
.
Urol Res
. 2006;34:41–46
.
MEDLINE |
CrossRef
8.
8
Serteser M
, Koken T
, Kahraman A
, Yilmaz K
, Akbulut G
, Dilek ON
.
Changes in hepatic TNF-α levels, antioxidant status, and oxidation product after renal ischemia/reperfusion injury in mice
.
J Sur Res
. 2002;107:234–240
.
9.
9
Finck BN
, Kelly DP
.
Peroxisome proliferator-activated receptor-α (PPAR-α) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart
.
J Mol Cell Cardiol
. 2002;34:1249–1257
.
Abstract |
Full-Text PDF (275 KB)
|
CrossRef
10.
10
Patel NS
, di Paola R
, Mazzon E
, Britti D
, Thiemermann C
, Cuzzocrea S
.
Peroxisome proliferator-activated receptor-alpha contributes to the resolution of inflammation after renal ischemia/reperfusion injury
.
J Pharmacol Exp Ther
. 2009;328:635–643
.
CrossRef
11.
11
Ahila S
, Chatterjee P
, Hattori Y
, Brown P
, Stewart K
, Todorovic Z
, et al.
Agonists of peroxisome-proliferator activated receptor- alpha (clofibrate and WY14643) reduce renal ischemia/reperfusion injury in the rat
.
Med Sci Monit
. 2002;8:532–539
.
12.
12
Kumari CS
, Govindasamy S
, Sukumar E
.
Lipid lowering activity of Eclipta prostrate in experimental hyperlipidemia
.
J Ethnopharmacol
. 2006;105:332–335
.
MEDLINE |
CrossRef
13.
13
Kontogiannis J
, Burns KD
.
Role of AT1 angiotensin II receptors in renal ischemic injury
.
Am J Physiol
. 1998;274(1 Pt 2):F79–F90
.
MEDLINE
14.
14
Slater TF
, Sawyer BC
.
The stimulatory effects of carbon tetrachloride and other halogenoalkanes or peroxidative reactions in liver fractions in vitro
.
Biochem J
. 1971;123:805–814
.
MEDLINE
15.
15
Levine RL
, Garland D
, Oliver CN
, Amici A
, Climent I
, Lenz AG
, et al.
Determination of carbonyl content in oxidatively modified proteins
.
In:
Packer L
, Glazer AN
editor.
Methods in Enzymology, Oxygen Radicals in Biological Systems
. 186:
California: Academic Press; 1990;p. 464–478
.
16.
16
Moran MS
, Depierre JW
, Mannervik B
.
Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver
.
Biochim Biophys Acta
. 1979;582:67
.
MEDLINE
17.
17
Misra HP
, Fridovich I
.
The role of superoxide anion in the auto- oxidation of epinephrine and a simple assay of SOD
.
J Biol Chem
. 1972;247:3170
.
MEDLINE
18.
18
Aebi H
.
Oxidoreductases acting on groups other than CHOH: catalase
.
In:
Colowick SP
, Kaplan NO
, Packer L
editor.
Methods in Enzymology
. 105:
London: Academic Press; 1984;p. 121–125
.
MEDLINE |
CrossRef
19.
19
Varley H
.
Practical Clinical Biochemistry
. New Delhi: CBS Publishers; 1988;
.
20.
20
Prajda N
, Weber G
.
Malignant transformation-linked imbalance: decreased xanthine oxidase activity in hepatomas
.
FEBS Lett
. 1975;59:245–249
.
MEDLINE |
CrossRef
21.
21
Guevara I
, Iwanejko J
, Dembinska-Kiec A
.
Determination of nitrite/nitrate in human biological material by the simple Griess reaction
.
Clin Chim Acta
. 1998;274:177–188
.
MEDLINE |
CrossRef
22.
22
Wei H
, Frenkel K
.
Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters
.
Carcinogenesis
. 1993;14:1195–1201
.
MEDLINE
23.
23
Huang E
, Kuo W
, Chen Y
, Chen T
, Chang M
, Lu M
, et al.
Homocysteine and other biochemical parameters in type 2 diabetes mellitus with different diabetic duration or diabetic retinopathy
.
Clin Chim Acta
. 2006;366:293–298
.
MEDLINE |
CrossRef
24.
24
Hagar HH
.
Folic acid and vitamin B12 supplementation attenuates isoprenaline-induced myocardial infarction in experimental hyperhomocysteinemic rats
.
Pharmacol Res
. 2002;46:213–219
.
MEDLINE |
CrossRef
25.
25
Matsuyama M
, Yoshimura R
, Hase T
, Kawahito Y
, Sano H
, Nakatani T
.
Study of cyclooxygenase-2 in renal ischemia-reperfusion injury
.
Transplant Proc
. 2005;37:370–372
.
Abstract | Full Text |
Full-Text PDF (57 KB)
|
CrossRef
26.
26
Arnhold J
, Osipov AN
, Spalteholz H
, Panasenko OM
, Schiller J
.
Effects of hypochlorous acid on unsaturated phosphatidylcholines
.
Free Radic Biol Med
. 2001;31:1111–1119
.
MEDLINE |
CrossRef
27.
27
Yagmurca M
, Erdogan H
, Iraz M
, Songur A
, Ucar M
, Fadillioglu E
.
Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats
.
Clin Chim Acta
. 2004;348:27–34
.
MEDLINE |
CrossRef
28.
28
Ma XL
, Lopez BL
, Liu GL
, Christopher TA
, Gao F
, Guo Y
, et al.
Hypercholesterolemia impairs a detoxification mechanism against peroxynitrite and renders the vascular tissue more susceptible to oxidative injury
.
Circ Res
. 1997;80:894–901
.
MEDLINE
29.
29
Onody A
, Csonka C
, Giricz Z
, Ferdinandy P
.
Hyperlipidemia induced by a cholesterol-rich diet leads to enhanced peroxynitrite formation in rat hearts
.
Cardiovasc Res
. 2003;58:663–670
.
MEDLINE |
CrossRef
30.
30
Dominique D
, Gele P
, Petrault O
, Six I
, Furman C
, Bouly M
, et al.
Peroxisome proliferator activated receptor-α activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment
.
J Neurosci
. 2003;23:6264–6271
.
31.
31
Chen XR
, Besson VC
, Palmier B
, Garcia Y
, Plotkine M
, Leroux CM
.
Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury
.
J Neurotrauma
. 2007;24:1119–1131
.
CrossRef
32.
32
Kładna A
, Aboul-Enein HY
, Kruk I
, Lichszteld K
, Michalska T
.
Scavenging of reactive oxygen species by some nonsteroidal anti- inflammatory drugs and fenofibrate
.
Biopolymers
. 2006;82:99–105
.
MEDLINE |
CrossRef
33.
33
Wu J
, Lin J
, He Z
, Ou B
, Guo H
.
Effect of hyperlipidemia on endothelial VCAM-1 expression and the protective role of fenofibrate
.
Front Med China
. 2007;1:356–358
.